<DOC>
	<DOCNO>NCT00669409</DOCNO>
	<brief_summary>To evaluate safety tolerability single IV dose PF-04383119 Japanese patient moderate severe pain OA knee ( Part I ) . To evaluate preliminary analgesic efficacy PF-04383119 Japanese patient moderate severe pain OA knee comparison placebo ( Part I Part II ) .</brief_summary>
	<brief_title>A Phase 1/2A , Single Dose Study Of PF-04383119 In Japanese Patients With Moderate To Severe Pain From Osteoarthritis Of The Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Japanese Male female , Age 3565 ( Part 1 ) , Age 3575 ( Part 2 ) Diagnosis osteoarthritis ( OA ) knee base American College Rheumatology criterion Knee pain , radiographic evidence knee OA ( KellgrenLawrence xray grade â‰¥2 ) obtain within 1 year enrollment At least one following : age &gt; 50 , morning stiffness &lt; 30 minute duration , crepitus , OA knee must involve index tibiofemoral joint must present least 6 month Patients meet least one following : unwilling take nonopiate pain medication , nonopiate pain medication fail , candidate seek invasive intervention intraarticular injection , knee arthroplasty , total knee surgery Pain level require protocol Screening Baseline Diagnosis history RA , inflammatory arthritis , gout , Paget 's disease disease Investigator 's opinion would interfere assessment pain symptom OA Patients regional pain syndrome suggestive fibromyalgia regional pain cause lumbar cervical compression radiculopathy risk develop radiculopathy . Diagnosis history fibromyalgia Planned surgical procedure duration study</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>monoclonal antibody</keyword>
</DOC>